Our ElectroNanospray™ process transforms drugs and polymers into many nanoscale material states including powders, liquids, encapsulated particles, and coatings. Use of this enabling technology platform allows the application of polymers and drugs to medical devices in a single-stage process as well as the formulation of drugs for enhanced therapeutic delivery.

The ability to nanoformulate compounds and/or apply those novel formulations as coatings onto the surfaces of medical devices is the value proposition that Nanocopoeia brings to the marketplace.

Nanocopoeia's business model is to provide value-added development and formulation services to corporate partners. Our key market sectors include cardiovascular diseases, orthopedics, neurology, and tissue engineering.

Beyond health care industry applications for this enabling platform, Nanocopoeia is seeking partners to grow industrial applications of the technology.